Clinical efficacy and complication trends of turp in managing benign prostatic hyperplasia
Abstract
Transurethral resection of the prostate (TURP) remains the gold-standard surgical treatment for benign prostatic hyperplasia (BPH). However, outcomes from peripheral and resource-limited settings in Pakistan are less frequently reported, where patient profiles and perioperative resources may differ from tertiary centers. Objective: To evaluate the clinical efficacy, perioperative outcomes, complication trends, and length of hospital stay among patients undergoing TURP. Methods: This retrospective cohort study reviewed records of 127 men aged 45–85 years who underwent TURP between November 2023 and March 2024 at Timergara DHQ Hospital Dir Lower and RHQ Skardu. The Patients with prior prostate surgery, malignancy, bladder stones, or urethral strictures were excluded. Data included demographics, prostate volume, operative time, pre- and postoperative hemoglobin and sodium levels, postoperative complications, and hospital stay. Statistical analysis was performed using SPSS v21, with significance set at p ≤ 0.05. Results: The mean age was 65.2 ± 10.3 years, and mean prostate volume was 66.8 ± 19.7 mL. A significant postoperative reduction in hemoglobin was observed (p < 0.01), while postoperative sodium changes were not significant (p = NS), indicating a low risk of TUR syndrome. Overall complication rates were low: blood transfusion 18%, sepsis 7%, TUR syndrome 1%, and bladder perforation 1%. The mean operative time was 125.6 ± 32.8 minutes, and the mean hospital stay was 4.1 ±…
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.